Levicept's Series A Round

Levicept raised a round of funding on October 08, 2014.

Levicept is an asset-centric UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. The company is progress…

Articles about Levicept's Series A Round: